Jiliang Wang

Publication Activity (10 Years)

Years Active: 2016-2021
Publications (10 Years): 6

Top Topics

Oxidative Stress

Ischemia Reperfusion Injury

Anti Inflammatory Drugs

Top Venues

Oxidative medicine and cellular longevity

Journal of oncology

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Ke Chen, Jianrong Guo, Tao Zhang, Jian Gu, Huili Li, Jiliang Wang
The Role of Dyslipidemia in Colitis-Associated Colorectal Cancer. Journal of oncology 2021 (2021)
Tao Zhang, Jianrong Guo, Jian Gu, Ke Chen, Huili Li, Jiliang Wang
Protective Role of mTOR in Liver Ischemia/Reperfusion Injury: Involvement of Inflammation and Autophagy. Oxidative medicine and cellular longevity 2019 (2019)
Tao Zhang, Jian Gu, Jianrong Guo, Ke Chen, Huili Li, Jiliang Wang
Renalase Attenuates Mouse Fatty Liver Ischemia/Reperfusion Injury through Mitigating Oxidative Stress and Mitochondrial Damage via Activating SIRT1. Oxidative medicine and cellular longevity 2019 (2019)
Jianrong Guo, Tao Zhang, Jian Gu, Kailin Cai, Xiuling Deng, Ke Chen, Kun Huang, Guobin Wang, Huili Li, Jiliang Wang
Oleic Acid Protects against Hepatic Ischemia and Reperfusion Injury in Mice by Inhibiting AKT/mTOR Pathways. Oxidative medicine and cellular longevity 2019 (2019)
Kun Huang, Ju Liu, Hui Zhang, Jiliang Wang, Huili Li
Intramyocardial Injection of siRNAs Can Efficiently Establish Myocardial Tissue-Specific Renalase Knockdown Mouse Model. BioMed research international 2016 (2016)
Huili Li, Jianrong Guo, Hongli Liu, Yanfeng Niu, Lixia Wang, Kun Huang, Jiliang Wang
Renalase as a Novel Biomarker for Evaluating the Severity of Hepatic Ischemia-Reperfusion Injury. Oxidative medicine and cellular longevity 2016 (2016)